Y-Intercept (HK)’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Y-Intercept (HK)’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-72,077	Closed	-$47.3K	–	1973
2025 Q1	$47.3K	Buy	+72,077	New	+$76.3K	﹤0.01%	1132
2024 Q3	–	Sell	-744,102	Closed	-$267K	–	1754
2024 Q2	$267K	Buy	+744,102	New	+$402K	0.01%	1068
2023 Q3	–	Sell	-98,590	Closed	-$128K	–	1534
2023 Q2	$128K	Buy	+98,590	New	+$135K	0.01%	1022
2022 Q4	–	Sell	-19,575	Closed	-$95.9K	–	1313
2022 Q3	$95.9K	Buy	+19,575	New	+$101K	0.01%	890

Other funds holding SGMO

YAG

Yorkville Advisors Global Mountainside, New Jersey $155M AUM 58.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Y-Intercept (HK)'s SGMO Position: Q2 2025 in Review

Y-Intercept (HK) sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2025, closing a stake of 72,077 shares — an estimated $47.3K sold.

Y-Intercept (HK) first reported a position in SGMO in Q3 2022 and held it in 4 quarters. The position peaked at $267K in Q2 2024. 114 funds tracked by Wall St. Rank hold SGMO as of Q2 2025.

Y-Intercept (HK) reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2025 after selling out during the quarter.
Y-Intercept (HK) sold 72,077 SANGAMO THERAPEUTICS INC shares in Q2 2025, an estimated $47.3K.
Y-Intercept (HK) first reported a position in SANGAMO THERAPEUTICS INC in Q3 2022 and held it in 4 quarters.
Y-Intercept (HK)'s SANGAMO THERAPEUTICS INC position peaked at $267K in Q2 2024.
114 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2025.

Based on Y-Intercept (HK)'s 13F filing for Q2 2025, filed 1 Aug 2025.